ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,981Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 2588

$1.11M Total Retail Price of All Prescriptions

Rank: 68 out of 2588

466 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

27% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 16,463 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 945 862 1 1
AMLODIPINE BESYLATE 732 641 2 4
LISINOPRIL 696 631 3 3
FUROSEMIDE 537 510 4 5
METOPROLOL TARTRATE 533 496 5 9
WARFARIN SODIUM 505 425 6 10
HYDROCODONE-ACETAMINOPHEN 416 329 S3 7 7
LEVOTHYROXINE SODIUM 403 398 8 2
METFORMIN HCL 386 309 9 8
HEPARIN SODIUM 349 247 10 79
NIFEDIPINE ER 337 295 11 59
PANTOPRAZOLE SODIUM 331 280 12 28
TAMSULOSIN HCL 314 278 13 23
OMEPRAZOLE 311 304 14 6
HYDROCHLOROTHIAZIDE 308 263 15 13
ATORVASTATIN CALCIUM 268 223 16 11
DONEPEZIL HCL 266 262 17 22
NAMENDA 253 253 18 32
EXELON 234 234 19 118
CARVEDILOL 230 208 20 20
FLUTICASONE PROPIONATE 222 197 21 40
GABAPENTIN 214 171 22 18
POTASSIUM CHLORIDE 207 170 23 15
NAPROXEN 204 153 24 95
FAMOTIDINE 197 173 25 36
METOPROLOL SUCCINATE 181 155 26 12
NOVOLOG 152 135 27 103
DIOVAN 150 122 28 29
CLONIDINE HCL 150 118 28 54
TRAMADOL HCL 146 104 30 19
MIRTAZAPINE 145 145 31 63
CLOPIDOGREL 136 118 32 30
ESCITALOPRAM OXALATE 129 116 33 68
LANTUS 129 124 33 47
TRAZODONE HCL 129 113 33 61
ENALAPRIL MALEATE 127 111 36 31
AMOX TR-POTASSIUM CLAVULANATE 124 103 37 131
ALLOPURINOL 122 118 38 33
ACETAMINOPHEN-CODEINE 115 100 S3 39 80
FINASTERIDE 111 88 40 97
ZOLPIDEM TARTRATE 110 100 41 24
PLAVIX 107 92 42 43
DIGOXIN 102 91 43 38
HYDRALAZINE HCL 101 92 44 53
ENOXAPARIN SODIUM 101 97 44 176
CITALOPRAM HBR 100 96 46 27
ATENOLOL 99 81 47 14
LACTULOSE 98 93 48 135
LYRICA 93 72 49 100
FENOFIBRATE 92 88 50 64
LEVOFLOXACIN 89 81 51 77
ABILIFY 88 86 52 134
BACLOFEN 85 47 53 142
LOVAZA 84 58 54 119
RANITIDINE HCL 79 68 55 37
AMITRIPTYLINE HCL 78 53 R 56 91
AZITHROMYCIN 78 66 56 45
LOSARTAN POTASSIUM 77 76 58 17
ADVAIR DISKUS 75 45 59 48
NIASPAN 75 63 59 115
SERTRALINE HCL 75 62 59 26
SINGULAIR 73 53 62 94
FLUDROCORTISONE ACETATE 71 71 63 379
COUMADIN 69 69 64 165
PREDNISONE 69 62 64 42
RISPERIDONE 68 59 66 57
LEVETIRACETAM 67 64 67 90
SANTYL 67 61 67 160
LEXAPRO 66 63 69 182
KLOR-CON M20 65 52 70 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 60 71 35
PROAIR HFA 61 44 72 50
SODIUM CHLORIDE 61 41 72 168
NIFEDICAL XL 60 59 74 179
ALENDRONATE SODIUM 59 56 75 21
GLIMEPIRIDE 58 58 76 39
VENTOLIN HFA 57 37 77 101
LIPITOR 56 45 78 114
LIDODERM 56 23 78 86
EASY TOUCH 55 38 80 397
GLIPIZIDE 53 42 81 44
PRADAXA 52 52 82 207
ISOSORBIDE MONONITRATE ER 52 52 82 49
PRAVASTATIN SODIUM 51 51 84 16
HUMALOG 51 43 84 141
NOVOLOG MIX 70-30 FLEXPEN 51 31 84 289
CYMBALTA 50 38 87 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.